PETS
NASDAQPetMed Express Inc.
SectorConsumer StaplesIndustryRetail-Drug Stores and Proprietary Stores
News · 26 weeks27+80%
2026-03-012026-08-23
Mix2590d
- SEC Filings9(36%)
- Insider7(28%)
- Other5(20%)
- Earnings4(16%)
Latest news
25 items- INSIDERInterim CEO and President Campbell Leslie C.G. was granted 60,000 shares, increasing direct ownership by 71% to 145,000 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by PetMed Express Inc.SCHEDULE 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
- SECPetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds® Announces First Quarter Financial ResultsDELRAY BEACH, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2026. Quarterly Highlights Net sales demonstrated sequential quarterly stabilization. For the first quarter ended June 30, 2026, net sales were $41.0 million compared to $51.2 million for the prior year period, a decrease of 19.9%, as lower consumer promotional usage was more than offset by a decline in prescription medication sales.Net loss for the quarter ended June 30, 2026, was $6.1 million, or $(0.28) per diluted share, compared to a net loss of $34.2 million, or $(1.65) per di
- SECPetMed Express Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERDirector Lacamp James was granted 55,555 shares, increasing direct ownership by 159% to 90,421 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Batushansky Peter was granted 55,555 shares, increasing direct ownership by 153% to 91,928 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Mennen Justin L. was granted 55,555 shares, increasing direct ownership by 130% to 98,274 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- PRPetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, on Thursday, August 13, 2026 after market close. The Company will host a conference call and webcast to review these results at 4:30pm Eastern Time on the same day. Date: Thursday, August 13, 2026Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast: 1Q Earnings Webcast A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day throu
- INSIDERAmendment: CAO and Interim CFO Krulik Douglas was granted 32,500 shares, increasing direct ownership by 46% to 102,500 units (SEC Form 4)4/A - PETMED EXPRESS INC (0001040130) (Issuer)
- SECPetMed Express Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 MillionDELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (NASDAQ:PETS), today announced that it has entered into a definitive agreement for a sale-leaseback transaction ("Transaction") with an institutional real estate investor involving the Company’s headquarters and distribution center buildings in Delray Beach, FL, for an aggregate purchase price of $37 million. The Transaction is subject to a due diligence period and satisfaction of certain customary closing conditions, including negotiation of a lease back to the Company of the portion of the sold properties housing the Company’s offices and Florida distribution center. Th
- PRPetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy PlatformDELRAY BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (NASDAQ:PETS), today announced that its new online pet pharmacy offering with Rural King is now available, giving Rural King customers convenient access to trusted pet medications, prescription food, preventatives and pet health products through a new co-branded online pharmacy experience powered by PetMeds. The new offering is accessible through RuralKing.com, where customers can click web banners that open a co-branded online experience powered by PetMeds. Customers will also be able to access the offering through Rural King email and social media promoti
- PRPetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments LimitedDELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds" or the "Company") (NASDAQ:PETS) today confirmed that its Board of Directors (the "Board") has received an unsolicited, non-binding, and conditional proposal from SilverCape Investments Limited ("SilverCape") to acquire all outstanding shares of the Company’s common stock for $3.00 per share in cash, following SilverCape’s prior unsolicited, non-binding, and conditional proposal of $4.00 per share made on December 11, 2025. Consistent with its fiduciary duties, the Board, with the assistance of its financial and legal advisors, will carefully evaluate the proposal to determine the course of action that it
- PRSilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in CashUnaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunning Destruction of Stockholder Value Board’s Failure to Properly Consider Strategic Alternatives Amid Ongoing Erosion of Value Could Leave Stockholders with Nothing SilverCape Calls on Directors to Act as Independent Fiduciaries and Engage in Good Faith with its Proposal or Run a Bona Fide Process to Sell the Company SINGAPORE, June 29, 2026 (GLOBE NEWSWIRE) -- SilverCape Investments Limited ("SilverCape"), a Singapore-based single family-office, today released an open letter to the board of directors (the "Board") of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS) calling o
- SECPetMed Express Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERCAO and Interim CFO Krulik Douglas was granted 32,500 shares, increasing direct ownership by 46% to 102,500 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECSEC Form DEFA14A filed by PetMed Express Inc.DEFA14A - PETMED EXPRESS INC (0001040130) (Filer)
- SECSEC Form DEF 14A filed by PetMed Express Inc.DEF 14A - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERLarge owner Nina Capital Holdings Inc. bought $43,725 worth of shares (25,000 units at $1.75), increasing direct ownership by 0.97% to 2,600,000 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECSEC Form 10-K filed by PetMed Express Inc.10-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECPetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial ResultsDELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026. Fourth Quarter Fiscal 2026 Financial Highlights Compared to Prior Year Period Net sales of $42.8 million compared to $50.8 million in the prior year period, a decrease of 15.6%, primarily driven by a decline in prescription medication sales.Net loss of $4.1 million, or $(0.19) per diluted share, compared to a net loss of $11.6 million, or $(0.56) per diluted share, for the prior year period. The decrease in the net loss can be attributed to lower general and
- PRPetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day. Date: Tuesday, June 2, 2026Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast: 4Q Earnings Webcast A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through Jun
PETS FAQ
6 questionsWhat does PetMed Express Inc. do?
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain...Where does PETS stock trade?
PetMed Express Inc. (PETS) is listed on NASDAQ.What sector and industry is PETS in?
PetMed Express Inc. operates in the Consumer Staples sector, Retail-Drug Stores and Proprietary Stores industry.What are analysts saying about PETS?
PetMed Express Inc. has had 6 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $2000.00 price target on 2023-05-25. Recent price targets range from $2000.00 to $3200.00.What companies are similar to PETS?
Notable peers in the same industry include CVS (CVS Health Corporation), WBA (Walgreens Boots Alliance Inc.), GRDN (Guardian Pharmacy Services Inc.), RAD (Rite Aid Corporation), MDVL (MedAvail Holdings Inc.). Compare PETS side-by-side with any of them on Quantisnow.How can I track PETS on Quantisnow?
Quantisnow aggregates PetMed Express Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETS to receive live email and push alerts on every new disclosure.